Pancreatic Cancer Resectable clinical trials

Explore recruiting pancreatic cancer resectable clinical trials.

Recruiting pancreatic cancer resectable studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Pancreatic Cancer Resectable trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Risk-adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOX FRENCH26 – PRODIGE93 - PANACHE02 Trial

France

Phase II and Phase III (Integrated) EU CTIS Study details

Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial

Netherlands, Finland, Sweden, Italy, Norway, Belgium +1 more

Therapeutic use (Phase IV) EU CTIS Study details

Pancreatic Cancer Resectable trials by city

Pancreatic Cancer Resectable clinical trials

Recruiting pancreatic cancer resectable studies right now

Intravital Microscopy in Human Solid Tumors

Conversion Surgery Vs. Palliative Care in Pancreatic Cancer Oligometastatic to the Liver

PULSAR in Systemic Therapy for Pancreatic Cancer

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

Initial Feasibility Study to Treat Borderline Resectable Pancreatic Cancer With a Planar LDR Source

A First-in-Human Study to Evaluate Implantable Iontophoresis Chemotherapy Delivery Device With Gemcitabine Once Weekly or Twice Weekly in Participants With Pancreatic Cancer

Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer

Medical Cannabis in Patients With Advanced Pancreatic and Colorectal Cancer

Antecolic Versus Retrocolic Gastrojejunostomy During Whipple's Procedure

Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic Cancer

A New Strategy for Preoperative Drainage of Resectable Pancreatic Head Cancer Combined Severe Obstructive Jaundice

A Study of ASP2138 Given Before Surgery, Then Chemotherapy After Surgery, in People With Pancreatic Ductal Cancer

Also recruiting in Europe

Risk-adapted adjuvant chemotherapy guided by the tumour stage for operated pancreatic adenocarcinoma following neoadjuvant chemotherapy with FOLFIRINOX FRENCH26 – PRODIGE93 - PANACHE02 Trial

Preventing postoperative complications in patients undergoing high-risk pancreatoduodenectomy with a bundle approach including hydrocortisone, ocreotide, and teres ligament patch (PANENCA): an international randomized controlled multicenter trial

Pancreatic Cancer Resectable trials by city

Other conditions